Sox9 Expression Is Not Limited to Chondroid Neoplasms: Variable Occurrence in Other Soft Tissue and Bone Tumors With Frequent Expression by Synovial Sarcomas

Abstract

The transcription factor Sox9 is known to play a crucial role in normal chondrogenesis, and antibodies against Sox9 have been proposed as a diagnostic tool for neoplasms with chondroid differentiation. However, the pattern of Sox9 immunohistochemical expression by other bone and soft tissue neoplasms, as well as its diagnostic specificity, remain unexplored. The authors have performed immunohistochemistry with antibodies against Sox9 in 106 chondroid and nonchondroid bone and soft tissue neoplasms. Moderate to intense Sox9 nuclear staining was observed in 14/20 chondrosarcomas (70%), and in 24/81 (29.6%) cases from a multitumor tissue microarray, which included 16/18 synovial sarcomas, 4/15 osteosarcomas, 2/5 peripheral primitive neuroectodermal tumor (PNET)/Ewing sarcomas, 1/1 mesenchymal chondrosarcoma, and 1/1 chondroblastoma. The results suggest that Sox9 usefulness in the diagnosis of chondroid tumors may be limited because of low sensitivity and specificity. The finding of Sox9 expression by 88.9% of synovial sarcomas represents a novel and striking observation, which deserves further investigation.

Keywords

Sox9 immunohistochemistry bone and soft tissue tumors chondrosarcoma synovial sarcoma

Get full access to this article

View all access options for this article.

References

Bell DM , Leung KKH , Wheatley SC , et al. Sox9 directly regulates the type-II collagen gene. Nat Genet. 1997;16: 174-178.

Bi W. , Deng JM , Zhaoping Z. , Behringer RR , Crombugghe B. Sox9 is required for cartilage formation. Nat Genet . 1999;22: 85-89.

Mori-Akiyama Y. , Akiyama H. , Rowitch DH , Crombugghe B. Sox9 is required for determination of the chondrogenic cell lineage in the cranial neural crest . Proc Natl Acad Sci U S A. 2003;100:9360-9365.

Akiyama H. , Kim JE , Nakashima K. , et al. Osteo-chondroprogenitor cells are derived from Sox9 expressing precursors. Proc Natl Acad Sci U S A. 2005 ;102:14665-14670.

Kawakami Y. , Rodriguez-Leon, Belmonte JCI. The role of TGFBs and Sox9 during limb chondrogenesis . Curr Opin Cell Biol. 2006;18:723-729.

Cheung M. , Briscoe J. Neural crest development is regulated by the transcription factor Sox9. Development. 2003;130:5681-5693.

Barrionuevo F. , Taketo MM , Scherer G. , Kispert A. Sox9 is required by notochord maintenance in mice. Dev Biol. 2006;295: 128-140.

Hanley KP , Oakley F. , Sugden S. , Wilson DI , Mann DI , Hanley NA Ectopic Sox9 mediates extracellular matrix deposition characteristic of organ fibrosis. J Biol Chem. 2008;283:14063-14071.

Machado I. , Giner F. , Mayordomo E. , Carda C. , Navarro S. , Llombart-Bosch A. Tissue microarrays analysis in chondrosarcomas: light microscopy, immunohistochemistry and xenograft study. Diagn Pathol. 2008;3:S25-S32.

10.

Soderstrom M. , Bohling T. , Ekfors T. , Nelimarkka L. , Aro HT , Vuorio E. Molecular profiling of human chondrosarcomas for matrix production and cancer markers. Int J Cancer. 2002;100:144-151.

11.

Schaefer JF , Millham ML , de Crombugghe B. , Buckbinder L. FGF signaling antagonizes cytokine-mediated repression of Sox9 in SW1353 chondrosarcoma cells. Osteoarthritis Cartilage. 2003;11:233-241.

12.

Wehrli BM , Huang W. , de Crombugghe B. , Ayala AG , Czerniak B. Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors. Hum Pathol. 2003;34:263-269.

13.

Oakley GJ , Fuhrer K. , Seethala RR Brachyury, Sox9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis . Mod Pathol. 2008;21:1461-1469.

14.

Veras EFT , Santamaria IB , Luna MA Sinonasal chondromyxoid fibroma. Ann Diagn Pathol. 2009;13:41-46.

15.

Konishi E. , Nakashima Y. , Iwasa Y. , Nakao R. , Yanagisawa A. Immunohistochemical analysis for Sox9 reveals the cartilaginous character of chondroblastoma and chondromyxoid fibroma of the bone. Hum Pathol. 2010;41:208-213.

16.

Won KY , Park HR , Park YK Prognostic implication of immunohistochemical Runx2 expression in osteosarcoma . Tumori. 2009;95:311-316.

17.

Kypriotou M. , Fossard-Demoor M. , Chadjichristos C. , et al. Sox9 exerts a bifunctional effect on type II collagen gene (COL2A1) expression in chondrocytes depending on the differentiation state. DNA Cell Biol. 2003;22:119-129.

18.

Akiyama H. , Chaboissier MC , Behringer RR , et al. Essential role of Sox9 in the pathway that controls formation of cardiac valves and septa. Proc Natl Acad Sci U S A. 2004;101:6502-6507.

19.

Milchgrub S. , Ghandur-Mnaymneh L. , Dorfman HD , Albores-Saavedra J. Synovial sarcoma with extensive osteoid and bone formation. Am J Surg Pathol. 1993;17:357-363.

20.

Allander SV , Illei PB , Chen Y. , et al. Expression profiling of synovial sarcoma by cDNA microarrays. Association of ERBB2, IGFBP2 and ELF3 with epithelial differentiation. Am J Pathol. 2002;161:1587-1595.

21.

Francis P. , Namlos HM , Muller C. , et al. Diagnostic and prognostic gene expression signature in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential. BMC Genomics. 2007;8:73-89.

22.

Hasegawa T. , Yokoyama R. , Matsuno Y. , Shimoda T. , Hirohashi S. Prognostic significance of histologic grade and nuclear expression of β-catenin in synovial sarcoma. Hum Pathol. 2001;32:257-263.

23.

Saito T. , Oda Y. , Yamamoto H. , et al. Nuclear β-catenin correlates with cyclin D1 expression in spindle and pleomorphic sarcomas but not in synovial sarcoma. Hum Pathol. 2006;37: 689-697.

24.

Pretto D. , Barco R. , Rivera J. , Neel N. , Gustavson MD , Eid JE The synovial sarcoma translocation protein SYT-SSX2 recruits β-catenin to the nucleus and associates with it in an active complex. Oncogene. 2006;25:3661-3669.

25.

Akiyama H. , Lyons JP , Mori-Akiyama Y. , et al. Interactions between Sox9 and β-catenin control chondrocyte differentiation. Genes Dev. 2004;18:1072-1087.

26.

Topol L. , Chen W. , Song H. , Day TF , Yang Y. Sox9 inhibits Wnt signaling by promoting β-catenin phosphorylation in the nucleus. J Cell Biol. 2009;284:3323-3333.